Avanos Medical, Inc.AVNSNYSE
Loading
Cash Flow Under PressureContracting
Percentile Rank29
3Y CAGR-6.3%
Studio
Year-over-Year Change

Cash generated from core business operations

3Y CAGR
-6.3%/yr
Annual compound
Percentile
P29
Within normal range
vs 3Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$74.70M-25.8%
2024$100.70M+210.8%
2023$32.40M-64.4%
2022$90.90M+4.1%
2021$87.30M+3592.0%
2020$-2.50M+96.6%
2019$-74.50M+48.8%
2018$-145.60M-201.0%
2017$144.20M-23.6%
2016$188.80M-